Literature DB >> 30249766

Telemedicine on the rise but lagging in Canada.

Brian Owens1.   

Abstract

Mesh:

Year:  2018        PMID: 30249766      PMCID: PMC6157497          DOI: 10.1503/cmaj.109-5634

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Extending the Reach and Task-Shifting Ophthalmology Diagnostics Through Remote Visualisation.

Authors:  Mario E Giardini; Iain A T Livingstone
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  Virtual care and the influence of a pandemic: Necessary policy shifts to drive digital innovation in healthcare.

Authors:  Patrick B Patterson; Jenna Roddick; Candice A Pollack; Daniel J Dutton
Journal:  Healthc Manage Forum       Date:  2022-06-30

3.  Determining the unmet needs of patients with intracranial meningioma-a qualitative assessment.

Authors:  Ami Baba; Melissa D McCradden; Jessica Rabski; Michael D Cusimano
Journal:  Neurooncol Pract       Date:  2019-10-29

Review 4.  Telemedicine curriculum in undergraduate medical education: a systematic search and review.

Authors:  Işıl İrem Budakoğlu; Mustafa Ünal Sayılır; Yavuz Selim Kıyak; Özlem Coşkun; Serdar Kula
Journal:  Health Technol (Berl)       Date:  2021-05-10

Review 5.  Virtual Care With Digital Technologies for Rural Canadians Living With Cardiovascular Disease.

Authors:  Ryan Buyting; Sarah Melville; Hanif Chatur; Christopher W White; Jean-François Légaré; Sohrab Lutchmedial; Keith R Brunt
Journal:  CJC Open       Date:  2021-12-23

6.  Will applications on smartphones allow a generalization of telemedicine?

Authors:  F A Allaert; L Legrand; N Abdoul Carime; C Quantin
Journal:  BMC Med Inform Decis Mak       Date:  2020-02-11       Impact factor: 2.796

7.  Evaluating paediatric orthopaedic teleradiology services at a tertiary care centre.

Authors:  Eva Habib; Wendy Krishnaswamy; Judy K Wu; Emily K Schaeffer; Kishore Mulpuri
Journal:  J Pediatr Orthop B       Date:  2022-01-01       Impact factor: 1.473

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.